Pfizer Philippines Sues Unilab For Alleged Lipitor Patent Infringement
This article was originally published in PharmAsia News
Executive Summary
Pfizer Philippines is suing United Laboratories of the Philippines, accusing it of violating Pfizer's patent for Lipitor (atorvastatin) for lowering high cholesterol